↓
 

Tag Archives: nivolumab ipilimumab

Drs. Jack West and Charu Aggarwal: New Data on Liquid Biopsies, Tumor Mutational Burden, and Choosing Optimal Systemic Therapy Today

Dr. Charu Aggarwal from University of Pennsylvania Abramson Cancer Center joins Dr. Jack West to discuss new data on plasma-based testing for tumor mutational burden (TMB) & the current state of liquid biopsies, TMB, & immunotherapy-based options today. (36:57)

Dr. Jarushka Naidoo: South African TV Personality, Dublin Medical Trainee, Shakespearean Stage Actor, and Johns Hopkins Immunotherapy Toxicity Expert

Dr. Jarushka Naidoo, medical oncologist at Johns Hopkins, speaks with host Jack West about her path from childhood TV star in South Africa, to medical training and stage acting in Dublin, to US-based expert on toxicities of cancer immunotherapy. (50:30)

Quality of Life on the Atezolizumab/Bevacizumab Combination for Metastatic Kidney Cancer: Highlights from ASCO 2018 (BMIC-054)

Dr. Daniel Goldstein reviews data from ASCO 2018 on patient-reported quality of life on atezolizumab/bevacizumab compared to sunitinib in metastatic kidney cancer, along with the context of other treatment options in this setting. (2:18)

Download MP3 Audio Version

↑